Washington Trust Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.4K Buy
220
+20
+10% +$6.57K 0.01% 333
2025
Q4
$70.1K Sell
200
-30
-13% -$10.1K 0.01% 327
2025
Q3
$74.3K Sell
230
-82
-26% -$25.5K 0.01% 314
2025
Q2
$121K Sell
312
-15
-5% -$6.03K 0.01% 242
2025
Q1
$142K Buy
327
+5
+2% +$2.01K 0.01% 223
2024
Q4
$119K Sell
322
-11
-3% -$4.6K 0.01% 240
2024
Q3
$173K Buy
333
+20
+6% +$10.7K 0.01% 212
2024
Q2
$170K Hold
313
0.02% 210
2024
Q1
$162K Buy
313
+6
+2% +$2.98K 0.01% 211
2023
Q4
$145K Buy
307
+8
+3% +$3.7K 0.01% 211
2023
Q3
$130K Hold
299
0.01% 216
2023
Q2
$133K Buy
299
+18
+6% +$8.3K 0.01% 210
2023
Q1
$129K Hold
281
0.01% 215
2022
Q4
$144K Sell
281
-195
-41% -$99K 0.02% 202
2022
Q3
$216K Sell
476
-4
-0.8% -$1.91K 0.02% 194
2022
Q2
$232K Sell
480
-17
-3% -$8.41K 0.02% 190
2022
Q1
$244K Sell
497
-355
-42% -$162K 0.02% 213
2021
Q4
$395K Buy
+852
New +$358K 0.03% 181

Other funds holding ELV

Washington Trust Advisors's ELV Position: Q1 2026 in Review

Washington Trust Advisors increased its Elevance Health (ELV) stake by 10% in Q1 2026, buying an estimated $6.57K and bringing the position to 220 shares worth $64.4K. The position accounts for 0.01% of the portfolio, ranked #333.

Washington Trust Advisors first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $395K in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Washington Trust Advisors held 220 shares of Elevance Health worth $64.4K as of Q1 2026.
  • Washington Trust Advisors bought 20 Elevance Health shares in Q1 2026, an estimated $6.57K.
  • Elevance Health made up 0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #333 holding.
  • Washington Trust Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • Washington Trust Advisors's Elevance Health position peaked at $395K in Q4 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.